| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.24 | 3e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 5e-05 |